Life Sciences Companies and European Privacy Requirements—An Overview of Recent Guidance Regarding the GDPR

Life Sciences Companies and European Privacy Requirements—An Overview of Recent Guidance Regarding the GDPR

Webinar
Speaking Engagement CLE

Related Event

Navigating Antitrust Issues in the Life Sciences Industry

Speaking Engagement

In this webinar, WilmerHale panelists will discuss recent developments in European data privacy that impact the life sciences industry and address how US-based and global life sciences organizations can navigate the rules established by the General Data Protection Regulation (GDPR). 

Topics will include the relevant activities of the European data protection authorities, in particular the new privacy guidance in preparation for the EU Clinical Trials Regulation (CTR) coming in 2020 that could significantly affect clinical trials in Europe and have broader implications for GDPR compliance and the protection of personal data in notification and consent forms and other areas. 

Our speakers will also provide an overview of current enforcement priorities and the status of privacy-related litigation across the European Union. 

View the Webinar Recording

*CLE credit is not available for those who watch webinar recordings.

Read More About the Event

Speakers

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.